Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia

Clinical trial NCT03705858 · WITHDRAWN

Trial details

NCT number: NCT03705858
Sponsor: Joseph Jurcic
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2019-02-28
Primary completion: 2019-02-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.